Instructions for Authors
Updated January 2023
The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials. All submissions to Clinical Diabetes will be reviewed by the editorial team and considered for publication if they contain information that would be helpful to the journal’s readership. All articles, whether invited or submitted, should be written with general practice, family practice, or internal medicine providers in mind as the main audience.
HOW CAN I SUBMIT AN ARTICLE TO THE JOURNAL?
Manuscripts may be submitted via http://mc.manuscriptcentral.com/clinical-diabetes. Before submitting an article, please review the information below and click on the appropriate link for further instructions related to the content and format of the article you wish to submit. The corresponding author should complete, sign, and return the manuscript submission form on behalf of all authors at the time of or soon after submitting an article. Once a manuscript is submitted, the review process generally takes 4–6 weeks. Failure to follow the manuscript preparation and submission instructions may delay the review process.
Feature articles present either original research or reviews of topics related to diabetes in primary practice.
Standing departments in Clinical Diabetes include:
- Case Studies
- Clinical Pharmacology Update
- Diabetes Advocacy
- Letter to the Editor
- Perspectives in Clinical Diabetes
- Practical Pointers
- Quality Improvement Success Stories
- Translating Research to Practice
For detailed instructions on writing these various types of articles, visit the Detailed Information for Authors page.
EDITORIAL OFFICE CONTACT INFORMATION
American Diabetes Association
9702 East Washington Street
Suite 400, #356
Indianapolis, IN 46229
Phone: (317) 354-1508, ext. 1782
Fax: (317) 547-4656
ADA’s Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for Clinical Diabetes have been adopted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of Clinical Diabetes. Comprehensive information related to the editorial and ethical policies of Clinical Diabetes can be found in Publication Policies and Procedures for ADA Journals. The Association's Publications Policy Committee or Subcommittee on Ethical Scientific Publications will consider on a case-by-case basis policies that are not addressed in the policies document, which contains information related to the following topics:
- Study Design
- Originality and Prior Publication
- Authorship and Contributions
- Conflict of Interest
- Data Access and Responsibility
- Clinical Trials, Systematic Reviews, and Meta-Analyses
- Digital Image Manipulation
- Responses to Possible Scientific Misconduct
- Peer Review
- Editorial Decisions
- Prepublication of Accepted Articles
- Reuse, Post-Prints, and Public Access
- Media Embargoes
Frequently referenced sections appear below. The complete document is available at: https://www.diabetesjournals.org/content/journal-policies.
Post-Prints and Public Access
Reuse. Authors are permitted to reuse portions of their ADA-copyrighted work, including tables and figures, in their own work, and to reuse portions or all of their ADA-copyrighted work for educational purposes without submitting a request to ADA, provided that the proper citation and copyright information is given.
Post-prints. Authors are permitted to submit their accepted manuscript to their funding body or institution for inclusion in their funding body or institution’s database, archive, or repository, or to post the accepted manuscript on their personal website. These manuscripts may be made freely accessible to the public upon acceptance if certain conditions are observed. For details, please refer to the section on Copyright, Reuse, and Public Access in Publication Policies and Procedures for ADA Journals.
Public access. As a courtesy to authors, the final print versions of articles will be deposited in PubMed Central (PMC). In compliance with National Institutes of Health policy, these articles will appear on PMC 12 months after print publication in Clinical Diabetes and will be indexed on PubMed/Medline. All content is freely accessible on the Clinical Diabetes website 12 months after the final print publication date.
To make new research readily available to subscribers, Clinical Diabetes publishes original research articles online ahead of print.
The designated corresponding author will receive notification of availability of page proofs by email. Corrections should be returned promptly upon receipt of the proof. Failure to do so may delay the publication of the article.
ADA partners with Kudos, a platform designed to help authors engage broad audiences with their work, while tracking usage and reach. The Kudos service is integrated with ADA’s peer-review system, where plain language summaries are captured for sharing, and authors are invited to access a comprehensive overview of their article usage, altmetric, and other behavioral data in a dashboard view. Upon acceptance, authors will receive an email invitation to register and view their dashboard and promote and track their article.